3B BlackBio Dx Ltd
3B BlackBio Dx Ltd (3BBLACKBIO) last traded at ₹1,254, a market capitalisation of ₹1,077 crore, on a P/E of 19.4. Over the past 52 weeks the stock has ranged between ₹1,084 and ₹1,750. 3B BlackBio Dx Ltd last reported results for the quarter ended Jun 2026, with sales of ₹33.49 crore and net profit of ₹8.98 crore. The next scheduled event is an analyst meet on 29 Aug 2026. Figures are as of 25 Aug 2026 and are not real time.
3B BlackBio Dx Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
3B BlackBio Dx Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹33.49 cr, up 50.7% from ₹22.23 cr a year earlier. Net profit was ₹8.98 cr, down 29.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 29.15 | 25.39 | 22.5 | 22.23 | 33.9 | 50.35 | 35.43 | 33.49 |
| Expenses | 12.98 | 10.32 | 14.58 | 10.4 | 19.17 | 28.63 | 26.94 | 24.97 |
| Operating profit | 16.17 | 15.07 | 7.92 | 11.83 | 14.73 | 21.72 | 8.49 | 8.52 |
| OPM % | 55.47% | 59.35% | 35.20% | 53.22% | 43.45% | 43.14% | 23.96% | 25.44% |
| Other income | 3.44 | 3.01 | 4.94 | 4.32 | 5.51 | 5.59 | 10.15 | 6.14 |
| Interest | 0.03 | 0.02 | 0.04 | 0.01 | 0.04 | 0.09 | 0.1 | 0.1 |
| Depreciation | 0.27 | 0.27 | 0.28 | 0.28 | 0.58 | 0.38 | 3.89 | 1.34 |
| Profit before tax | 19.31 | 17.79 | 12.54 | 15.86 | 19.62 | 26.84 | 14.65 | 13.22 |
| Tax % | 22.99% | 24.17% | 35.89% | 20.30% | 23.34% | 16.39% | 33.11% | 32.07% |
| Net profit | 14.87 | 13.49 | 8.04 | 12.65 | 15.04 | 22.44 | 9.81 | 8.98 |
| EPS (₹) | 17.07 | 15.61 | 9.79 | 14.67 | 17.14 | 25.32 | 11.14 | 11.10 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
3B BlackBio Dx Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 227 | 81 | 62 | 74 | 96 | 142 | 153 |
| Operating profit | 150 | 37 | 29 | 33 | 50 | 57 | 53 |
| OPM % | 66% | 46% | 47% | 44% | 52% | 40% | 35% |
| Net profit | 114 | 32 | 26 | 32 | 48 | 60 | 56 |
| EPS (₹) | 151.66 | 42.89 | 34.55 | 37.40 | 55.57 | 68.27 | 64.70 |
TTM is the trailing twelve months to the most recent quarter.
3B BlackBio Dx Ltd growth and returns
- 10 Years
- 23%
- 5 Years
- -9%
- 3 Years
- 32%
- TTM
- 54%
- 10 Years
- 68%
- 5 Years
- -12%
- 3 Years
- 31%
- TTM
- 13%
- 10 Years
- 61%
- 5 Years
- 18%
- 3 Years
- 28%
- 1 Year
- -11%
- 10 Years
- 27%
- 5 Years
- 18%
- 3 Years
- 18%
- Last Year
- 20%
3B BlackBio Dx Ltd shareholding pattern
Promoters held 40.95% at Jun 2026, broadly unchanged since Jun 2025. FIIs 2.50% and DIIs 2.15%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 41.28% | 41.28% | 41.28% | 41.28% | 41.28% | 41.27% | 40.94% | 40.95% |
| FIIs | 3.27% | 2.68% | 2.49% | 2.70% | 2.64% | 2.57% | 2.57% | 2.50% |
| DIIs | 1.96% | 1.74% | 1.60% | 1.76% | 1.82% | 1.87% | 1.98% | 2.15% |
| Public | 53.48% | 54.29% | 54.64% | 54.28% | 54.26% | 54.27% | 54.50% | 54.40% |
| No. of shareholders | 9,586 | 10,166 | 10,345 | 10,619 | 10,709 | 10,507 | 10,616 | 11,049 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming 3B BlackBio Dx Ltd events
The next scheduled event is an analyst meet on 29 Aug 2026.
- Analyst meetOne-on-one analyst/investor meeting with Param Capital
See the full results calendar for every Indian company reporting in the next 30 days.
3B BlackBio Dx Ltd corporate filings
- Analyst/ Investor Meet IntimationCompany Updatelow impact
Cruxal's analysis: 3B BlackBio Dx Ltd has issued an intimation regarding an upcoming analyst/investor…
Read the full analysis - Newspaper Publication of Unaudited Financial Results for the quarter ended 30th June, 2026Company Updatelow impact
Cruxal's analysis: 3B BlackBio Dx Limited has released its unaudited standalone and consolidated financial…
Read the full analysis - Investor''s PresentationCompany Updatehigh impact
Cruxal's analysis: 3B BlackBio Dx Limited reported Q1 2026-27 consolidated revenue of 33.49 crore, up from…
Read the full analysis - Outcome of Board Meeting held on 13th August, 2026Board Meetinghigh impact
Cruxal's analysis: 3B BlackBio Dx Limited reported consolidated financial results for the quarter ended June…
Read the full analysis - 3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Unaudited Standalone and ....Board Meetinglow impact
Cruxal's analysis: 3B BlackBio Dx Limited has formally intimated the BSE regarding a Board of Directors…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track 3B BlackBio Dx Ltd
Cruxal reads every 3B BlackBio Dx Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.